Connell and O'Reilly Families Cell Manipulation Core Facility
The Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF) is a critical component of our cellular therapies program, processing almost 1,400 cellular products each year, including cells for more than 600 adult and pediatric stem cell transplants.
The CMCF also supports more than 40 diverse active clinical research protocols, with a focus on translational research in stem cell transplantation and immune therapy for cancer. It is among the largest cellular therapies labs at an academic medical
center and New England's only Class 10,000 Good Manufacturing Practices (GMP) cellular manufacturing facility.